Alerts will be sent to your verified email
Verify Email
NGLFINE
|
NGL Fine-Chem
|
Hikal
|
Sequent Scientific
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceutical Sector
|
|||
|
Total reactor capacity
|
457.0 kL | 3459.0 kL | n/a |
|
R&D as a % of Total Sales
|
1.8 % | 4.42 % | 0.0 |
|
Financials
|
|||
|
5 yr Average ROE
|
18.68 % | 9.85 % | -0.13 % |
|
5yr average Equity Multiplier
|
1.37 | 2.2 | 2.16 |
|
5yr Average Asset Turnover Ratio
|
1.03 | 0.77 | 0.95 |
|
5yr Avg Net Profit Margin
|
12.56 % | 5.73 % | 0.03 % |
|
Price to Book
|
2.98 | 2.61 | 7.1 |
|
P/E
|
40.29 | 52.04 | 168.64 |
|
5yr Avg Cash Conversion Cycle
|
24.74 Days | 40.84 Days | 49.09 Days |
|
Inventory Days
|
47.94 Days | 60.35 Days | 80.25 Days |
|
Days Receivable
|
84.83 Days | 105.26 Days | 79.76 Days |
|
Days Payable
|
83.75 Days | 105.0 Days | 114.46 Days |
|
5yr Average Interest Coverage Ratio
|
25.7 | 4.65 | 1.93 |
|
5yr Avg ROCE
|
24.83 % | 12.68 % | 6.67 % |
|
5yr Avg Operating Profit Margin
|
18.08 % | 16.33 % | 7.74 % |
|
5 yr average Debt to Equity
|
0.16 | 0.65 | 0.53 |
|
5yr CAGR Net Profit
|
-18.08 % | -7.37 % | -25.52 % |
|
5yr Average Return on Assets
|
13.76 % | 4.51 % | 0.05 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
72.74 % | 68.85 % | 52.61 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-1.07 % | 0.08 % | -0.18 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 2.2 % | 9.79 % |
|
NGL Fine-Chem
|
Hikal
|
Sequent Scientific
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|